Fundz
Real-time · AI · Cross-signal

Alvotech and Advanz Pharma just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Alvotech and Advanz Pharma, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Alvotech and Advanz Pharma Announce EMA Acceptance of Marketing Authorization Application for AVT06, a Proposed Biosimilar to Eylea®

Aug 15, 2024•almost 2 years ago

Contract Type

partnership

ManufacturingBiotechnologyPharmaceutical

Description

Alvotech and Advanz Pharma announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept), marking a step closer to making AVT06 available in Europe to provide patients with more treatment options.

Company Information

Company

Alvotech and Advanz Pharma

About

Alvotech is a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide. Advanz Pharma is a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe.

Predictive Intelligence
Strategic

ML-powered predictions for Alvotech and Advanz Pharma's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.